All lobbying filings
THORN RUN PARTNERS
THORN RUN PARTNERS filed a Q2 report for EXELIXIS on July 20, 2026, reporting $60,000 in lobbying income.
Lobbying for EXELIXIS · Genomics-based drug discovery company
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
California
Lobbyists on this filing
1
-
CATHERINE FINLEYPreviously held: Staff Director, Senate Special Aging Committee; Senior Health Policy Advisor, Sen. Smith; Legislative Asst, Sen. Snowe
Government bodies contacted
2
Lobbying activity
2
Tracking implementation of prescription drug pricing policies included as part of the Inflation Reduction Act (IRA).
Policies related to creating incentives for innovation in the life sciences.